Former FDA Deputy To Pay $127,496 For Insider Trading Role Involving Generics
NEW YORK — A former Food and Drug Administration deputy director turned industry lobbyist was enjoined Nov. 14 from violating the Securities Exchange Act for his role in giving FDA insider...To view the full article, register now.
Already a subscriber? Click here to view full article